Holen Sie sich die Stockscreener-App
83.92
0.77%
0.64
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EW?
Forum
Prognose
Aktiensplit
Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten
Scott Ullem Sells 7,700 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Vega Investment Solutions Has $28,000 Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by Natixis - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Ossiam - MarketBeat
Edwards Lifesciences’ Markowitz sells $50k in stock By Investing.com - Investing.com Canada
Edwards Lifesciences Corporation $EW Stock Position Increased by 2Xideas AG - MarketBeat
Edwards Lifesciences’ Markowitz sells $50k in stock - Investing.com
Barclays Raises Edwards Lifesciences (EW) Price Target to $103.0 - GuruFocus
Leerink Partners Adjusts Edwards Lifesciences PT to $87 From $88, Maintains Market Perform Rating - marketscreener.com
WINTON GROUP Ltd Acquires 43,197 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences stock price target raised to $95 from $90 at Bernstein - Investing.com
Invesco Ltd. Decreases Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $100.00 at Royal Bank Of Canada - MarketBeat
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat
Epoch Investment Partners Inc. Has $20.45 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW): Stifel Raises Price Target to $100 | - GuruFocus
Edwards Lifesciences (EW) Sees Analyst Target Price Increase Tod - GuruFocus
Amundi Raises Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
UBS Maintains Neutral Rating on Edwards Lifesciences (EW) and Ra - GuruFocus
Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? - Yahoo Finance
Edwards Lifesciences (EW) Analyst Rating Update for December 5, 2025 | EW Stock News - GuruFocus
Edwards Lifesciences (EW): Reassessing Valuation After Upbeat 2025–2026 Outlook and TAVR Growth Signals - Yahoo Finance
Edwards Lifesciences Sets Cautious Targets Yet Keeps Investors Interested - Finimize
Edwards Lifesciences : EW 2025 IC FINAL - marketscreener.com
Bernstein Adjusts Edwards Lifesciences Price Target to $95 From $90, Maintains Market Perform Rating - marketscreener.com
Wells Fargo Adjusts Price Target for Edwards Lifesciences (EW) | - GuruFocus
Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says - marketscreener.com
Edwards Lifesciences Bags Prosthetic Valve Patent In EU - Law360
Truist Securities Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus
How Do Investors Really Feel About Edwards Lifesciences Corp? - Benzinga
Edwards Lifesciences stock hits 52-week high at 87.42 USD By Investing.com - Investing.com Nigeria
Edwards Lifesciences stock hits 52-week high at 87.42 USD - Investing.com
Raymond James Adjusts PT on Edwards Lifesciences to $100 From $96, Maintains Outperform Rating - marketscreener.com
UBS Adjusts Price Target on Edwards Lifesciences to $92 From $90, Maintains Neutral Rating - marketscreener.com
Edwards Lifesciences price target raised to $92 from $90 at UBS - Investing.com
RBC Capital raises Edwards Lifesciences stock price target to $100 on 2026 outlook - Investing.com
Truist Securities Adjusts PT on Edwards Lifesciences to $92 From $90, Maintains Hold Rating - marketscreener.com
Edwards Lifesciences price target raised to $100 from $95 at Stifel - TipRanks
RBC Raises Price Target on Edwards Lifesciences to $100 From $95, Keeps Outperform Rating - marketscreener.com
Stifel Adjusts Price Target on Edwards Lifesciences to $100 From $95, Maintains Buy Rating - marketscreener.com
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $96 From $95, Maintains Overweight Rating - marketscreener.com
Barclays Adjusts Price Target on Edwards Lifesciences to $103 From $99, Maintains Overweight Rating - marketscreener.com
Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $89 From $84, Maintains Hold Rating - marketscreener.com
Edwards Lifesciences price target raised to $89 from $84 at Canaccord - TipRanks
Edwards Lifesciences stock price target raised to $92 from $90 at Truist - Investing.com Nigeria
Analyst BTIG Raises Price Target for Edwards Lifesciences (EW) t - GuruFocus
Edwards Lifesciences stock price target raised to $100 by Stifel - Investing.com South Africa
Edwards Lifesciences price target raised to $96 from $95 at Wells Fargo - TipRanks
Does Edwards Lifesciences’ Analyst Day Transcatheter Pipeline Update Reframe the Bull Case for EW? - simplywall.st
Edwards Lifesciences stock price target raised to $89 from $84 at Canaccord - Investing.com
Edwards Lifesciences stock price target raised to $103 from $100 at BTIG - Investing.com
Edwards Lifesciences Corporation $EW Shares Sold by Brown Advisory Inc. - MarketBeat
Edwards Lifesciences: Strategic Initiatives and Promising Developments Drive Raised Price Target - TipRanks
Edwards Lifesciences price target raised to $103 from $100 at BTIG - TipRanks
Edwards Lifesciences: A Strong Growth Opportunity in Medtech with Expanding Market Potential and Robust Product Portfolio - TipRanks
Edwards Lifesciences : 2025 Investor Conference - marketscreener.com
Edwards outlines strategy for sustained growth - MassDevice
Edwards Lifesciences (EW) Revises FY25 Revenue Projection Upward - GuruFocus
Edwards Lifesciences Reiterates 2025 Guidance; 2026 Forecast Issued - marketscreener.com
Edwards Lifesciences sees FY26 adjusted EPS $2.80-$2.95, consensus $2.86 - TipRanks
Edwards Lifesciences reaffirms strategy for sustainable, differentiated growth at annual investor conference - marketscreener.com
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference - Yahoo Finance
Promising Outlook for Edwards Lifesciences: TAVR Expansion and Strong Growth Prospects Drive Buy Rating - TipRanks
Edwards Lifesciences Corporation $EW Shares Sold by Northwestern Mutual Wealth Management Co. - MarketBeat
Groupe la Francaise Purchases 16,834 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
1.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):